Medical News

RSS

Study: Generic nifedipine product not bioequivalent to Adalat XL

An extended release generic nifedipine product (Mylan-Nifedipine extended release 60 mg formerly Gen-Nifedipine extended release 60mg, Genpharm ULC) is not bioequivalent to the Canadian originator product, Adalat(R) XL(R), according to the results of a study recently published in the International Journal of Clinical Pharmacology and Therapeutics.

4 Feb 2010

National consensus reached on Joint Technical Statement for drug products

A pan-Canadian initiative was announced today that will ultimately have a major impact on patient safety by reducing preventable medication errors.

4 Feb 2010

Canadian Institutes of Health Research awards $2.3M for study on integrative biology of inflammatory diseases

A research team led by Dr. John D. Rioux, a researcher at the Montreal Heart Institute (MHI) and professor in the faculty of medicine at the Université de Montréal, has been awarded a grant of more than $2.3 million to finance a major research project on the integrative biology of inflammatory diseases. From among the roughly 70 applications submitted, Dr. Rioux's team is one of six selected by the Canadian Institutes of Health Research to receive the Emerging Team Grant - From Genes to Proteins, Cells, Tissues and Patients.

4 Feb 2010

Organizations across Canada unite as partners to prevent chronic diseases among Canadians

More than 30 organizations from across Canada are uniting as partners in a series of initiatives designed to improve the health of Canadians by preventing chronic disease. A total of $15.5 million is being invested in seven collaborative coalitions addressing such issues as childhood obesity, screening for chronic disease by family doctors, and the unique needs of First Nations communities.

4 Feb 2010

GKAS volunteers provide free dental care for children

With an economy that might cause some parents to postpone regular dental visits for their children and tooth decay being the most prevalent chronic disease in America's children, the American Dental Association (ADA) is mobilizing dental professionals for the eighth consecutive year in a national campaign to extend necessary care to children and adolescents from low-income families.

4 Feb 2010

Geisinger Health System and TGen sign research agreement

Geisinger Health System and the Translational Genomics Research Institute today announced the signing of a strategic research agreement that provides a focused look at the gaps in clinical medicine where biomedical research can make a difference.

4 Feb 2010

Cardiac Science announces global voluntary recall of certain AEDs

Cardiac Science Corporation is initiating a worldwide voluntary recall after determining that approximately 12,200 automated external defibrillators (AEDs) may not be able to deliver therapy during a resuscitation attempt, which may lead to serious adverse events or death. These AEDs were manufactured in a way that makes them potentially susceptible to failure under certain conditions. The FDA has been informed of this situation.

4 Feb 2010

Prolactin reduces the levels of BCL6 protein and prevents aggressive breast cancer

Researchers from the Kimmel Cancer Center at Jefferson have found a mechanism by which a hormone responsible for milk production blocks an oncogene that makes breast cancer more aggressive.

4 Feb 2010

Fluorochemicals used in nonstick cookware and similar products to be phased out amidst toxic concerns

Amid concern about the potential toxic effects of the fluorochemicals used in nonstick cookware, water-repellent clothing, and other consumer products, manufacturers are using new versions of these chemicals that may be safer. That's the topic of the cover story in the current issue of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

4 Feb 2010

Despite improvements, aid delivery bottlenecks persist in Haiti

Three weeks after a major earthquake struck Haiti, challenges in getting aid to those in need persist, the Washington Post reports. "Rajiv Shah, the administrator of the U.S. Agency for International Development, said the relief effort has escalated in recent days and will continue to do so.

4 Feb 2010

MedQuist to acquire Spheris' domestic business

MedQuist Inc., a leading provider of medical transcription software and services, today announced that it has agreed to purchase the domestic business of Spheris Inc., a global provider of clinical documentation technology and services that recently filed for Chapter 11 bankruptcy protection.

4 Feb 2010

Recent clinical trials in patients with ALBP show that SOMA 250 mg reduces disability

A recent analysis of two pivotal clinical trials in patients with acute low back pain (ALBP) who were treated with SOMA® (carisoprodol) 250 mg showed significantly improved functionality and reduced disability after three days of treatment, as measured by the Roland-Morris Disability Questionnaire (RMDQ).

4 Feb 2010

ACCP and FIRS honor World Cancer Day

During the 2010: The Year of the Lung campaign, the American College of Chest Physicians (ACCP) and other members of the Forum of International Respiratory Societies (FIRS) are honoring World Cancer Day, February 4, by elevating the awareness of lung cancer in terms of prevalence and prevention, as well as the amount of funding the disease receives for research in diagnosis and management.

4 Feb 2010

EPMA Journal promotes new philosophy in patient treatment

Springer and the European Association for Predictive, Preventive and Personalised Medicine have founded, as the Association's official publication, the EPMA Journal.

4 Feb 2010

Sudden infant death syndrome linked to low serotonin levels

Taking the next step in more than 20 years of research, researchers at Children's Hospital Boston have linked sudden infant death syndrome (SIDS) with low production of serotonin in the brainstem, based on a comparison of brainstem samples from infants dying of SIDS compared to brainstems of infants dying from other, known causes.

4 Feb 2010

P&G joins existing Navigenics investors in $18M Series C financing

Navigenics, a leading personal genomics company, announced today that the company has raised approximately $18 million of funding. The Procter and Gamble Company, with a worldwide portfolio of leading consumer brands, has joined existing Navigenics investors Kleiner Perkins Caufield and Byers and Mohr Davidow Ventures who also participated in this financing round.

4 Feb 2010

State round up: Florida considers eliminating popular Medicaid plan; State program for low-income adults changing in Minn.

e year the state of Florida eliminates its popular MediPass program, which gives more than half a million Medicaid recipients, mostly aged and disabled Floridians, an alternative to HMOs. Hints of its demise showed up in the governor's budget and letters from a powerful lawmaker.

4 Feb 2010

Repligen receives USPTO Notice of Allowance for patent covering a recombinant form of Protein A

Repligen Corporation announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office for a patent covering a recombinant form of Protein A which is identical in structure to the commercial form of Protein A from Staphylococcus aureus which is used in the production of many of the world's approved monoclonal antibodies. The patent, which will remain in force until 2028, covers a new Repligen proprietary product which is now available in commercial quantities.

4 Feb 2010

Findings provide potential new targets to combat malaria

Yale University researchers have found more than two dozen scent receptors in malaria-transmitting mosquitoes that detect compounds in human sweat, a finding that may help scientists to develop new ways to combat a disease that kills 1 million people annually.

4 Feb 2010

New vaccine to prevent malaria infection shown promise to protect young children

A new vaccine to prevent the deadly malaria infection has shown promise to protect the most vulnerable patients - young children - against the disease, according to an international team of researchers led by the University of Maryland School of Medicine's Center for Vaccine Development (CVD) and the Malaria Research and Training Center at the University of Bamako in Mali, West Africa.

4 Feb 2010

Medical News

Study: Generic nifedipine product not bioequivalent to Adalat XL

National consensus reached on Joint Technical Statement for drug products

Canadian Institutes of Health Research awards $2.3M for study on integrative biology of inflammatory diseases

Organizations across Canada unite as partners to prevent chronic diseases among Canadians

GKAS volunteers provide free dental care for children

Geisinger Health System and TGen sign research agreement

Cardiac Science announces global voluntary recall of certain AEDs

Prolactin reduces the levels of BCL6 protein and prevents aggressive breast cancer

Fluorochemicals used in nonstick cookware and similar products to be phased out amidst toxic concerns

Despite improvements, aid delivery bottlenecks persist in Haiti

MedQuist to acquire Spheris' domestic business

Recent clinical trials in patients with ALBP show that SOMA 250 mg reduces disability

ACCP and FIRS honor World Cancer Day

EPMA Journal promotes new philosophy in patient treatment

Sudden infant death syndrome linked to low serotonin levels

P&G joins existing Navigenics investors in $18M Series C financing

State round up: Florida considers eliminating popular Medicaid plan; State program for low-income adults changing in Minn.

Repligen receives USPTO Notice of Allowance for patent covering a recombinant form of Protein A

Findings provide potential new targets to combat malaria

New vaccine to prevent malaria infection shown promise to protect young children

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News